Cost-effectiveness of blinatumomab for the treatment of B­precursor acute lymphoblastic leukemia pediatric patients with high­risk first­relapse in Mexico.

Diaz Martinez, Juan Pablo; de Maraumont, Therese Aubry; Camacho, Luis Miguel; Garcia, Laura

Cost-effectiveness of blinatumomab for the treatment of Bprecursor acute lymphoblastic leukemia pediatric patients with highrisk firstrelapse in Mexico.

Diaz Martinez, Juan Pablo; de Maraumont, Therese Aubry; Camacho, Luis Miguel; Garcia, Laura.

Afiliação

Diaz Martinez JP; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. Electronic address: juan.diaz.martinez@mail.utoronto.ca.
de Maraumont TA; Health Economics Amgen Mexico, Mexico City, Mexico.
Camacho LM; Health Economics Amgen Mexico, Mexico City, Mexico.
Garcia L; Medical Amgen Mexico, Mexico City, Mexico.

Leuk Res ; 145: 107560, 2024 Aug 22.

Article em En | MEDLINE | ID: mdl-39214018

Palavras-chave

Acute lymphoblastic leukaemia; Blinatumomab; Cost-effectiveness; Mixture-cure models, Mexico; Pediatric

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2024 Tipo de documento: Article